HPV Circulating Tumor DNA Assay_2021

TECHNOLOGY NUMBER: 2021-390
Technology No. 2021-390

OVERVIEW

This is a multiplex ddPCR-based assay that enables early identification of HPV-associated cancers and the recurrence of such cancers. This early identification can empower physicians to make responsive changes in cancer treatment.

  • swap_vertical_circlemode_editInventor (4)
    Chandan Bhambhani
    John Brenner
    Muneesh Tewari
    Paul Swiecicki
  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    HPV Circulating Tumor DNA Assay_2021.pdf
Questions about this technology?